Home/Filings/4/0001209191-20-034731
4//SEC Filing

Krainer Adrian R. 4

Accession 0001209191-20-034731

CIK 0001623526other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 5:27 PM ET

Size

5.4 KB

Accession

0001209191-20-034731

Insider Transaction Report

Form 4
Period: 2020-06-03
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2020-06-03+14,77714,777 total
    Exercise: $26.53Exp: 2030-06-02Common Stock (14,777 underlying)
Footnotes (1)
  • [F1]The option shall fully vest on June 3, 2021 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date.

Issuer

Stoke Therapeutics, Inc.

CIK 0001623526

Entity typeother

Related Parties

1
  • filerCIK 0001780081

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:27 PM ET
Size
5.4 KB